Allianz Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-100,482
| Closed | -$382K | – | 2108 |
|
|
2020
Q1 | $382K | Sell |
100,482
-2,752
| -3% | -$10.5K | ﹤0.01% | 1713 |
|
|
2019
Q4 | $525K | Sell |
103,234
-551
| -0.5% | -$2.8K | ﹤0.01% | 1908 |
|
|
2019
Q3 | $525K | Sell |
103,785
-151,124
| -59% | -$764K | ﹤0.01% | 1883 |
|
|
2019
Q2 | $1.57M | Buy |
254,909
+10,644
| +4% | +$65.7K | ﹤0.01% | 1610 |
|
|
2019
Q1 | $1.13M | Sell |
244,265
-1,390
| -0.6% | -$6.45K | ﹤0.01% | 1720 |
|
|
2018
Q4 | $1.03M | Sell |
245,655
-8,964
| -4% | -$37.7K | ﹤0.01% | 1669 |
|
|
2018
Q3 | $1.6M | Buy |
254,619
+21,635
| +9% | +$136K | ﹤0.01% | 1642 |
|
|
2018
Q2 | $1.87M | Sell |
232,984
-1,330
| -0.6% | -$10.7K | ﹤0.01% | 1548 |
|
|
2018
Q1 | $1.75M | Buy |
234,314
+35,462
| +18% | +$265K | ﹤0.01% | 1544 |
|
|
2017
Q4 | $1.18M | Sell |
198,852
-2,671
| -1% | -$15.9K | ﹤0.01% | 1685 |
|
|
2017
Q3 | $1.48M | Sell |
201,523
-2,679
| -1% | -$19.7K | ﹤0.01% | 1585 |
|
|
2017
Q2 | $1.39M | Sell |
204,202
-3,635
| -2% | -$24.7K | ﹤0.01% | 1593 |
|
|
2017
Q1 | $1.96M | Sell |
207,837
-3,173
| -2% | -$30K | ﹤0.01% | 1508 |
|
|
2016
Q4 | $1.82M | Sell |
211,010
-10,634
| -5% | -$91.9K | ﹤0.01% | 1507 |
|
|
2016
Q3 | $1.4M | Buy |
+221,644
| New | +$1.4M | ﹤0.01% | 1596 |
|